Recognition of Non-operating Income, Non-operating Expenses and Extraordinary Loss
Perseus Proteomics Inc. (the Company)
An impairment loss was recorded on fixed assets in accordance with the Accounting Standard for Impairment of Fixed Assets. The reasons for the other individual items were Not disclosed
Non-operating income: government grants ¥19.316 million, insurance proceeds ¥10.000 million, interest income ¥3.329 million. Non-operating expenses: illness and injury condolence payments ¥10.000 million, foreign exchange losses ¥3.790 million, stock issuance costs ¥2.328 million. Extraordinary loss: impairment loss ¥4.024 million
Cumulative period for the second quarter (interim period) of the fiscal year ending March 2027
Reflected in the "Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Non-consolidated)" published today
| Item | Details |
|---|---|
| Event name | Recognition of Non-operating Income, Non-operating Expenses and Extraordinary Loss |
| Subject Entity | Perseus Proteomics Inc. (the Company) |
| Cause | An impairment loss was recorded on fixed assets in accordance with the Accounting Standard for Impairment of Fixed Assets. The reasons for the other individual items were Not disclosed |
| Amount of Impact on Business Performance | Non-operating income: government grants ¥19.316 million, insurance proceeds ¥10.000 million, interest income ¥3.329 million. Non-operating expenses: illness and injury condolence payments ¥10.000 million, foreign exchange losses ¥3.790 million, stock issuance costs ¥2.328 million. Extraordinary loss: impairment loss ¥4.024 million |
| Accounting period in which recognized | Cumulative period for the second quarter (interim period) of the fiscal year ending March 2027 |
| Impact on Earnings Forecast | Reflected in the "Summary of Financial Results for the Second Quarter (Interim Period) of the Fiscal Year Ending March 2027 [Japanese GAAP] (Non-consolidated)" published today |
Items this document does not state (19)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The Company explains that an impairment loss was recorded on fixed assets in accordance with the Accounting Standard for Impairment of Fixed Assets. No details are provided on the reasons for the other individual income and expense items.